Strategies of Macrophages to Maintain Bone Homeostasis and Promote Bone Repair: A Narrative Review
Source abstract
Abstract
Bone homeostasis (a healthy bone mass) is regulated by maintaining a delicate balance between bone resorption and bone formation. The regulation of physiological bone remodeling by a complex system that involves multiple cells in the skeleton is closely related to bone homeostasis. Loss of bone mass or repair of bone is always accompanied by changes in bone homeostasis. However, due to the complexity of bone homeostasis, we are currently unable to identify all the mechanisms that affect bone homeostasis. To date, bone macrophages have been considered a third cellular component in addition to osteogenic spectrum cells and osteoclasts. As confirmed by co-culture models or in vivo experiments, polarized or unpolarized macrophages interact with multiple components within the bone to ensure bone homeostasis. Different macrophage phenotypes are prone to resorption and formation of bone differently. This review comprehensively summarizes the mechanisms by which macrophages regulate bone homeostasis and concludes that macrophages can control bone homeostasis from osteoclasts, mesenchymal cells, osteoblasts, osteocytes, and the blood/vasculature system. The elaboration of these mechanisms in this narrative review facilitates the development of macrophage-based strategies for the treatment of bone metabolic diseases and bone defects.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Metabolism and Diseases · Bone health and treatments · Bone and Joint Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan 430000, China
Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200000, China
Funding
National Natural Science Foundation of China · the Key Research and Development Program of Hubei Province · Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund · Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University
References (100+)
Show source-provided references
1. Adiponectin Reduces Bone Stiffness: Verified in a Three-Dimensional Artificial Human Bone Model In Vitro10.3389/fendo.2018.00236 ↗
2. Traditional Chinese decoction Si Zhi Wan attenuates ovariectomy (OVX)-induced bone loss by inhibiting osteoclastogenesis and promoting apoptosis of mature osteoclasts10.3389/fphar.2022.983884 ↗
3. Comprehensive analysis of the differential expression and prognostic value of COL1A2 in colon adenocarcinoma10.18632/aging.204261 ↗
4. COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion
5. Amler, A.K., Dinkelborg, P.H., Schlauch, D., Spinnen, J., Stich, S., Lauster, R., Sittinger, M., Nahles, S., Heiland, M., and Kloke, L. (2021). Comparison of the Translational Potential of Human Mesenchymal Progenitor Cells from Different Bone Entities for Autologous 3D Bioprinted Bone Grafts. Int. J. Mol. Sci., 22.10.3390/ijms22020796 ↗
6. Picone, G., Cappadone, C., Pasini, A., Lovecchio, J., Cortesi, M., Farruggia, G., Lombardo, M., Gianoncelli, A., Mancini, L., and Ralf, H.M. (2020). Analysis of Intracellular Magnesium and Mineral Depositions during Osteogenic Commitment of 3D Cultured Saos2 Cells. Int. J. Mol. Sci., 21.10.3390/ijms21072368 ↗
7. Crosslinking induces high mineralization of apatite minerals on collagen fibers10.1016/j.ijbiomac.2018.02.136 ↗
8. HSP22 (HSPB8) positively regulates PGF2α-induced synthesis of interleukin-6 and vascular endothelial growth factor in osteoblasts10.1186/s13018-021-02209-8 ↗
9. Regulation of bone remodeling by vitamin K210.1111/odi.12624 ↗
10. Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation10.7554/eLife.07217 ↗
11. Exosome: Function and Application in Inflammatory Bone Diseases10.1155/2021/6324912 ↗
12. Origin of Reparative Stem Cells in Fracture Healing10.1007/s11914-018-0458-4 ↗
13. Hypoxia modifies the polarization of macrophages and their inflammatory microenvironment, and inhibits malignant behavior in cancer cells
14. Role of osteal macrophages in bone metabolism10.4132/jptm.2015.02.02 ↗
15. Neuroblastoma-secreted exosomes carrying miR-375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells10.1080/20013078.2020.1774144 ↗
16. Three-dimensional co-culture of mesenchymal stromal cells and differentiated osteoblasts on human bio-derived bone scaffolds supports active multi-lineage hematopoiesis in vitro: Functional implication of the biomimetic HSC niche10.3892/ijmm.2016.2712 ↗
17. High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease10.3389/fimmu.2019.02236 ↗
18. QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism10.1038/s41419-020-2548-3 ↗
19. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption10.1016/j.cell.2021.02.002 ↗
20. Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway10.1038/s41598-017-11246-5 ↗
21. Recent advances in osteoclast biology10.1007/s00418-018-1636-2 ↗
22. A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity10.1016/j.abb.2018.05.014 ↗
23. Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts10.1002/jbmr.1885 ↗
24. P2X7 receptor acts as an efficient drug target in regulating bone metabolism system10.1016/j.biopha.2020.110010 ↗
25. Inflammation, mesenchymal stem cells and bone regeneration10.1007/s00418-018-1643-3 ↗
26. Local administration of stromal cell-derived factor-1 promotes stem cell recruitment and bone regeneration in a rat periodontal bone defect model10.1016/j.msec.2015.04.002 ↗
27. The osteocyte: A multifunctional cell within the bone10.1016/j.aanat.2019.151422 ↗
28. Iwasaki, Y., Yamato, H., and Fukagawa, M. (2018). TGF-Beta Signaling in Bone with Chronic Kidney Disease. Int. J. Mol. Sci., 19.10.3390/ijms19082352 ↗
29. Mechanisms of bone development and repair10.1038/s41580-020-00279-w ↗
30. Osteoblast-osteoclast interactions10.1080/03008207.2017.1290085 ↗
31. The Osteocyte: New Insights10.1146/annurev-physiol-021119-034332 ↗
32. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism10.1016/j.bone.2018.10.007 ↗
33. Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion10.1007/s00774-018-0939-7 ↗
34. Importance of osteocyte-mediated regulation of bone remodelling in inflammatory bone disease
35. Activating the unfolded protein response in osteocytes causes hyperostosis consistent with craniodiaphyseal dysplasia10.1093/hmg/ddx339 ↗
36. Pannexin-1 and P2X7-Receptor Are Required for Apoptotic Osteocytes in Fatigued Bone to Trigger RANKL Production in Neighboring Bystander Osteocytes10.1002/jbmr.2740 ↗
37. Jaggi, U., Yang, M., Matundan, H.H., Hirose, S., Shah, P.K., Sharifi, B.G., and Ghiasi, H. (2020). Increased phagocytosis in the presence of enhanced M2-like macrophage responses correlates with increased primary and latent HSV-1 infection. PLoS Pathog., 16.10.1371/journal.ppat.1008971 ↗
38. Human Mesenchymal Stem Cell-Educated Macrophages Are a Distinct High IL-6-Producing Subset that Confer Protection in Graft-versus-Host-Disease and Radiation Injury Models10.1016/j.bbmt.2017.02.018 ↗
39. Significance of Macrophage Subtypes in the Peripheral Blood of Children with Systemic Juvenile Idiopathic Arthritis10.1007/s40744-021-00385-x ↗
40. Kim, J.M., Lin, C., Stavre, Z., Greenblatt, M.B., and Shim, J.H. (2020). Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells, 9.10.3390/cells9092073 ↗
41. Osteoimmunology: Inflammatory osteolysis and regeneration of the alveolar bone10.1111/jcpe.13056 ↗
42. Rochette, L., Meloux, A., Rigal, E., Zeller, M., Cottin, Y., and Vergely, C. (2019). The Role of Osteoprotegerin and Its Ligands in Vascular Function. Int. J. Mol. Sci., 20.10.3390/ijms20030705 ↗
43. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα10.1007/s00011-018-1209-9 ↗
44. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway10.1074/jbc.RA119.009521 ↗
45. Lee, K., Seo, I., Choi, M.H., and Jeong, D. (2018). Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology. Int. J. Mol. Sci., 19.10.3390/ijms19103004 ↗
46. Coupling of bone resorption and formation by RANKL reverse signalling10.1038/s41586-018-0482-7 ↗
47. Osteoporosis treatment: Recent developments and ongoing challenges10.1016/S2213-8587(17)30188-2 ↗
48. Mechanically-induced GDF15 Secretion by Periodontal Ligament Fibroblasts Regulates Osteogenic Transcription10.1038/s41598-019-47639-x ↗
49. (5R)-5-hydroxytriptolide (LLDT-8) prevents collagen-induced arthritis through OPG/RANK/RANKL signaling in a rat model of rheumatoid arthritis10.3892/etm.2016.3739 ↗
50. Yang, D.H., and Yang, M.Y. (2019). The Role of Macrophage in the Pathogenesis of Osteoporosis. Int. J. Mol. Sci., 20.10.3390/ijms20092093 ↗
51. OPG Production Matters Where It Happened10.1016/j.celrep.2020.108124 ↗
52. Komori, T. (2019). Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2. Int. J. Mol. Sci., 20.10.3390/ijms20071694 ↗
53. Epigenetic mechanisms in bone
54. Yoshida, C.A., Komori, H., Maruyama, Z., Miyazaki, T., Kawasaki, K., Furuichi, T., Fukuyama, R., Mori, M., Yamana, K., and Nakamura, K. (2012). SP7 inhibits osteoblast differentiation at a late stage in mice. PLoS ONE, 7.10.1371/journal.pone.0032364 ↗
55. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression10.1038/sj.onc.1207676 ↗
56. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: Roles of osterix, an osteoblast-related transcription factor10.1016/j.matbio.2005.09.001 ↗
57. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts10.1016/S0092-8674(00)80258-5 ↗
58. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-110.1002/jcp.21941 ↗
59. Regulation of osteoblast differentiation by Runx210.1007/978-1-4419-1050-9_5 ↗
60. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation10.1016/S0092-8674(01)00622-5 ↗
61. Ubiquitin-specific protease 53 promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells10.1038/s41419-021-03517-x ↗
62. The role of osteocalcin in regulation of glycolipid metabolism and muscle function in children with osteogenesis imperfecta10.3389/fendo.2022.898645 ↗
63. Komori, T. (2020). Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle. Int. J. Mol. Sci., 21.10.3390/ijms21207513 ↗
64. Phosphate/pyrophosphate and MV-related proteins in mineralisation: Discoveries from mouse models10.7150/ijbs.4538 ↗
65. Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma10.1016/j.omto.2020.01.010 ↗
66. Cathepsin K: The Action in and Beyond Bone10.3389/fcell.2020.00433 ↗
67. Tissue-Resident T Cells and Other Resident Leukocytes10.1146/annurev-immunol-042617-053214 ↗
68. The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases10.3389/fimmu.2021.664871 ↗
69. The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice via Suppression of Osteoclast Formation and Bone Resorption10.3389/fphar.2017.00627 ↗
70. Calf thymus polypeptide improved hematopoiesis via regulating colony-stimulating factors in BALB/c mice with hematopoietic dysfunction10.1016/j.ijbiomac.2020.03.041 ↗
71. Gambari, L., Grassi, F., Roseti, L., Grigolo, B., and Desando, G. (2020). Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis. Int. J. Mol. Sci., 21.10.3390/ijms21176001 ↗
72. Common signalling pathways in macrophage and osteoclast multinucleation10.1242/jcs.216267 ↗
73. Resorbing bone is chemotactic for monocytes10.1038/275132a0 ↗
74. Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation10.1002/jcp.22879 ↗
75. Zur, Y., Rosenfeld, L., Keshelman, C.A., Dalal, N., Guterman-Ram, G., Orenbuch, A., Einav, Y., Levaot, N., and Papo, N. (2018). A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapy. PLoS Biol., 16.10.1371/journal.pbio.2002979 ↗
76. CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release10.7554/eLife.35546 ↗
77. Lee, D., Ko, W.K., Kim, S.J., Han, I.B., Hong, J.B., Sheen, S.H., and Sohn, S. (2021). Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro. Pharmaceutics, 13.10.3390/pharmaceutics13040462 ↗
78. TNX deficiency results in bone loss due to an increase in multinucleated osteoclasts10.1016/j.bbrc.2019.03.134 ↗
79. Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway10.1038/s41419-018-0540-y ↗
80. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance10.1038/nature05894 ↗
81. HDAC9 Inhibits Osteoclastogenesis via Mutual Suppression of PPARγ/RANKL Signaling10.1210/me.2014-1365 ↗
82. Bai, M., Han, Y., Wu, Y., Liao, J., Li, L., Wang, L., Li, Q., Xing, W., Chen, L., and Zou, W. (2019). Targeted genetic screening in mice through haploid embryonic stem cells identifies critical genes in bone development. PLoS Biol., 17.10.1371/journal.pbio.3000350 ↗
83. Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes10.1155/2018/6354787 ↗
84. Diabetes and Its Effect on Bone and Fracture Healing10.1007/s11914-015-0286-8 ↗
85. Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects10.1016/j.cmet.2015.12.010 ↗
86. Orphan Nuclear Receptor ERRα Controls Macrophage Metabolic Signaling and A20 Expression to Negatively Regulate TLR-Induced Inflammation10.1016/j.immuni.2015.07.003 ↗
87. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-410.1111/cas.14344 ↗
88. Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1β axis in mice10.1038/srep22511 ↗
89. Cancer-associated adipocytes as immunomodulators in cancer10.1186/s40364-020-00257-6 ↗
90. Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs10.1080/2162402X.2021.1898753 ↗
91. Enhanced osteoclastogenesis by mitochondrial retrograde signaling through transcriptional activation of the cathepsin K gene10.1111/nyas.12709 ↗
92. Osteal macrophages support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model10.1002/jbmr.4413 ↗
93. Osteoclasts and Macrophages-Their Role in Bone Marrow Cavity Formation During Mouse Embryonic Development10.1002/jbmr.4629 ↗
94. Orthopaedic wear particle-induced bone loss and exogenous macrophage infiltration is mitigated by local infusion of NF-κB decoy oligodeoxynucleotide10.1002/jbm.a.36169 ↗
95. Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Shen, W.R., Qi, J., Nara, Y., Pramusita, A., Kinjo, R., and Mizoguchi, I. (2020). Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. Int. J. Mol. Sci., 21.10.3390/ijms21145169 ↗
96. Tumor Necrosis Factor Alpha Promotes Osteoclast Formation Via PI3K/Akt Pathway-Mediated Blimp1 Expression Upregulation10.1002/jcb.25672 ↗
97. Ohori, F., Kitaura, H., Ogawa, S., Shen, W.R., Qi, J., Noguchi, T., Marahleh, A., Nara, Y., Pramusita, A., and Mizoguchi, I. (2020). IL-33 Inhibits TNF-α-Induced Osteoclastogenesis and Bone Resorption. Int. J. Mol. Sci., 21.10.3390/ijms21031130 ↗
98. Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System10.3389/fimmu.2020.00058 ↗
99. Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp110.1002/stem.703 ↗
100. Exosomal miR-125a-5p derived from silica-exposed macrophages induces fibroblast transdifferentiation10.1016/j.ecoenv.2020.110253 ↗